维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：作者名="CLOTET B"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of danmavir-ritanavir at week 48 in treatment-experienced patients with HIV-1 infeellon in POWER 1 and 2:a pooled subgroup analysis of data from two randomised trlals显示文摘	Clotet B Bellos N Cooper D	2007	Lancet2007，369，9568：	1
2	Antiretroviral drug Resistance testing in adults infected with human immunodeficiency virus type 1:2003 recommendations of an International AIDS Society-USA Panel显示文摘	Hirsch MS Brun-Vezinet F Clotet B	2003	Clin Infect Dis2003，37，1：	1
3	RNA interference of HIV replication显示文摘	Martinez MA Clotet B Este JA	2002	Trends Immunol2002，23，：	1
4	Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia显示文摘	LAZZARIN A CLOTET B COOPER D	2003	N Engl J Med2003，348，22：	1
5	Update of the drug resistance mutations in HIV-1:2005显示文摘	JOHNSON V A BRUN-VEZINET F CLOTET B	2005	Top HIV Med2005，13，1：	1
6	Update of the drug resistance mutations in HIV-1:Fall 2005显示文摘	Johnson VA Brun-Vezinet F Clotet B	2005	Top HIV Med2005，13，4：	1
7	Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia显示文摘	Lazzarin A Clotet B Cooper D	2003	N Engl J Med2003，348，：	1
8	Rilpivirine versus efavirenz with two background nucleoside or nude- otide reverse transcriptase inhibitors in treatment-naive adults infec- ted with HIV-1 (THRIVE) : A phase 3, randonfised, non-inferiority trial 显示文摘	COHEN C J ANDRADE-VILLANUEVA J CLOTET B	2011	Lancet2011，378，9787：	1
9	Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial 显示文摘	Azzarin A Campbell T Clotet B	2007	Lancet2007，370，9581：	1
10	Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1:2003 recommendations of an international AIDS society-USA panel显示文摘	Hirsch MS Brun-Vezinet F Clotet B	2003	Clin Infec Dis2003，37，：	1
11	Update of the drug resistance mutations in HIV-1 显示文摘	Johnson VA Brun VF Clotet B	2005	Top HIV Med2005，13，4：	1
12	Update of the drug resistance mutations in HIV-I :2007 显示文摘	JOHNSON VA BRUN-V 6 ZINET F CLOTET B	2007	Top HIV Med2007，15，4：	1
13	Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia显示文摘	LAZZARIN A CLOTET B COOPER D	2003	N Engl J Med2003，348，：	1
14	Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type I:2003 recommendations of an International AIDS Society-USA panel显示文摘	Hirsch MS Brun-Vezinet F Clotet B	2003	Clin Infect Dis2003，37，：	1
15	Comparison of the f-HPV typingTM and Hybrid Capture Ⅱ? assays for detection of high-risk HPV genotypes in cervical samples显示文摘	Canadas M P Cirigliano V Darwich L Sirera G Coll J Clotet B	2012	J Virol Methods2012，183，：	1
16	Update of the drug resistance mutations in HIV-1显示文摘	Johnson VA Brun-V e zinet F Clotet B	2005	Top HIV Med2005，13，4：	1
17	Drug resistance mutations in HIV-1显示文摘	Johnson VA Brun - Vezinet F Clotet B	2003	TOP HIV Med2003，11，：	1
18	Drug resistance mutations in HIV- 1 显示文摘	Johnson VA Brun-Vezinet F Clotet B	2003	Top HIV Med2003，11，6：	1
19	The anti-HIV-1 activity of ADS -J1 targets the HIV-1 gp120显示文摘	Armand-Ugon M Clotet-Codina I Tintori C Manetti F Clotet B Botta M Este JA	2005	Virology2005，343，1：	1
20	TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals显示文摘	Reynes J Amsteh K Clotet B	2007	AIDS Patient Care STDS2007，21，8：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示